Navigation Links
China Shenghuo Reports Full Year 2007 Financial Results
Date:4/1/2008

-- (203,826)

Taxes and related payables (2,171,207) 1,848,555

Net Cash (Used in) Provided by

Operating Activities (5,036,769) 1,500,401

Cash Flows from Investing

Activities:

Receivable from related parties 67,018 (37,795)

Restricted cash 487,056 (76,001)

Capital expenditures (176,453) (180,737)

Acquisition of land use rights -- (20,295

Net Cash (Used in) Provided by

Investing Activities 377,621 (314,828)

Cash Flows from Financing

Activities:

Payable to related parties (312,391) --

Purchase of minority interest -- (274,780)

Proceeds from short and long-term

loans 15,491,257 2,581,672

Payments on short and long-term

loans (12,960,626) (2,401,605)

Issuance of common stock for cash 1,094,382 1,264,696

Proceeds from exercise of warrants 250,000 --

Net Cash Provided by Financing

Activities 3,562,622 1,169,983

Effect of exchange rate changes on

cash 205,729 231,839

Net Increase (Decrease) in Cash and

Cash Equivalents (890,797) 2,587,395

Cash and Cash Equivalents at

Beginning of Period 3,691,438 1,104,043

Cash and Cash Equivalents at End of

Period $ 2,800,641 $ 3,691,438

CHINA SHENGHUO PHARMACEUTICAL HOLDINGS,
'/>"/>

SOURCE China Shenghuo Pharmaceutical Holdings, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

Related medicine news :

1. China Shenghuo Pharmaceutical Holdings, Inc. Schedules Conference Call to Discuss FY 2007 Results
2. China Medicine Corporation to Present at Brean Murray Carret & Co. Mainland China Investor Tour
3. China Yingxia International, Inc. Announces Record Fourth Quarter and Year 2007 Results
4. China Yingxia International Announces Soybean Milk Production Lines Acquisition
5. Cells from the Research Institute of the MUHC on the road to China
6. China Medicine Announces Record Fourth Quarter and Fiscal Year 2007 Results
7. China Yingxia International Announces 2007 Fourth Quarter and Full Year Financial Results Conference Call
8. China Medicine Announces Conference Call to Discuss Fourth Quarter and Fiscal Year 2007 Results
9. China RuiTai International Holdings Retains CCG Elite for Investor Relations Services
10. China Medical Technologies Receives CE Mark for Two ECLIA Analyzers and 15 Reagents
11. Sinovac to Present at the Brean Murray, Carret & Co. Fourth Investor Tour of China
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2008)...stCall/ -- Universal Health,Realty Income Trust (...ded their,Board of Trustees with the appointment ...rsal Health Services, Inc. (UHS). Mr. Miller brin...lthcare leadership roles. He has,served as UHS, ...e Division,since 2007 and prior to that, served a...
(Date:12/4/2008)...ant gene could ease sickle-cell disease and thalas...4, 2008 -- Researchers at Children,s Hospital Bost...ancer Institute have identified a way to get red b...y made only before birth or by young infants. This...nd beta-thalassemia -- life-threatening inherited ...
(Date:12/4/2008)...en Joffe, Craig Joffe, and,Alan Buckey today file...,Securities and Exchange Commission. The group p...4% of LCA-Vision, Inc. (Nasdaq: LCAV ), which,o...ction centers in 33 states,in the United States. ...CEO of,LCAV. Craig Joffe is the former Chief Ope...
(Date:12/4/2008)..." , , WASHINGTON, Dec. 4 /PRNewswire-USNews...into question the safety of the Centers for Diseas...dministering multiple vaccines concurrently. , ...sorder Patients, published last week in PLOS One ...Hopkins Kennedy Krieger Institute and Massachusett...
Breaking Medicine News(10 mins):Health News:Turning back the Clock in Inherited Anemias 2Health News:Turning back the Clock in Inherited Anemias 3Health News:Turning back the Clock in Inherited Anemias 4Health News:11.4% Shareholders & Former Executive Management of LCA-Vision Seek Board Representation and Executive Management Positions 2Health News:11.4% Shareholders & Former Executive Management of LCA-Vision Seek Board Representation and Executive Management Positions 3Health News:11.4% Shareholders & Former Executive Management of LCA-Vision Seek Board Representation and Executive Management Positions 4Health News:11.4% Shareholders & Former Executive Management of LCA-Vision Seek Board Representation and Executive Management Positions 5Health News:11.4% Shareholders & Former Executive Management of LCA-Vision Seek Board Representation and Executive Management Positions 6Health News:Researchers & Department of Defense Question Multiple Vaccine Administration 2
...vitamin is a must in the medicine chest of a pregn...ic acid could lead to serious birth defects// in t... the risk of stroke and heart disease. Now, there ...a Dutch study has shown. Folic acid may actually ...
...hters and no sons, may have a greater risk of gett...A team of Israeli researchers compared families of... and found that having more daughters and risk of ... The Journal of the National Cancer Institute stu...
...ple the number of influenza cases over the last fo...da, according to statistics released by the Public...uns from October to late March or early April and ...onitors likely outbreaks during this time. Sympto...
...ed on the data put together in health maps, show t...irst 10 unhealthiest places.// Valley areas have ...rchers suggest inner-city areas will soon overtake...wing obesity crisis in South Wales has become more...
Other Medicine News:Health News:Gender Of Children May Be Linked To Risk Of Prostate Cancer 2Health News:Lifestyles Cause Concern To Welsh Health Officials 2
(Date:12/3/2008)...SAN DIEGO, Dec. 3 Vical ... exclusive, binding letter of intent with EIP,Ecz...rketing of the company,s,Allovectin-7(R) immunoth...ish,Republic of Northern Cyprus. EIP has agreed t...he territory and to pay Vical upfront and mileston...
(Date:12/2/2008)...CHICAGO, Dec. 3 Breast-... detection of cancers not found on mammograms or b...oday at the annual meeting of,the Radiological So...identify the most difficult to detect breast cance...achel F. Brem, M.D., professor of,radiology and d...
(Date:12/2/2008)...LENEXA, Kan., Dec. 2 IBT Laborator...l-research laboratory specializing in immunology a...two tests to evaluate the response of patients w...imary immunodeficiency disorder, chemotherapy drug...rugs to prevent rejection of a transplant. The com...
(Date:12/2/2008)...SKOKIE, Ill., Dec. 2 Horizon Thera... company, today announced that two pivotal,Phase ...ct candidate, HZT-501,met all primary endpoints....tion product containing ibuprofen and famotidine, ...n in the incidence of non-steroidal,anti-inflamma...
Breaking Medicine Technology:Vical Signs Binding Letter of Intent for Sales and Marketing of Allovectin-7(R) in Turkey 2Vical Signs Binding Letter of Intent for Sales and Marketing of Allovectin-7(R) in Turkey 3Vical Signs Binding Letter of Intent for Sales and Marketing of Allovectin-7(R) in Turkey 4Vical Signs Binding Letter of Intent for Sales and Marketing of Allovectin-7(R) in Turkey 5New Breast Imaging Technology Targets Hard-to-Detect Cancers 2New Breast Imaging Technology Targets Hard-to-Detect Cancers 3IBT Laboratories Expands its Menu of Tests for Immune Deficiency 2Horizon Therapeutics Announces Two Pivotal HZT-501 Phase 3 Trials Meet Primary Endpoints 2Horizon Therapeutics Announces Two Pivotal HZT-501 Phase 3 Trials Meet Primary Endpoints 3Horizon Therapeutics Announces Two Pivotal HZT-501 Phase 3 Trials Meet Primary Endpoints 4Hospitals still not smoke free 13512 1Hospitals still not smoke free 13512 2Smith 26 Nephew Introduces New Biologic to Speed Healing 13508 1Smith 26 Nephew Introduces New Biologic to Speed Healing 13508 2Smith 26 Nephew Introduces New Biologic to Speed Healing 13508 3Unique Line of Custom Made Orthotics for Sandals and Clogs Cater to Style Minded Foot Pain Sufferers 13504 1Unique Line of Custom Made Orthotics for Sandals and Clogs Cater to Style Minded Foot Pain Sufferers 13504 2Edwards Lifesciences Announces First Human Implants of Next Generation Transcatheter Heart Valve 3725 1Edwards Lifesciences Announces First Human Implants of Next Generation Transcatheter Heart Valve 3725 2Edwards Lifesciences Announces First Human Implants of Next Generation Transcatheter Heart Valve 3725 3
.... Contributing Editor , ,Celiac disease (CD) ... intestine that is triggered in genetically suscep...ining grains wheat, rye, barley, and possibly oats...vation of both a T-cell and B-cell immune response..., and crypt hyperplasia, and is self-perpetuating ...
...Francois Rossi Medical Hematology and Oncology CHU...n (CRP) is an acute-phase protein that has long be.... CRP measurement can complement a range of diagno...ment. However, as economic rationalization become...t is apparent that such areas of frequent laborato...
Other Medicine Technology:Non-Invasive Diagnostic Tests for Celiac Disease 2Non-Invasive Diagnostic Tests for Celiac Disease 3Near-Patient Testing: The Advantages of C-Reactive Protein in Hematological Testing 2Near-Patient Testing: The Advantages of C-Reactive Protein in Hematological Testing 3Near-Patient Testing: The Advantages of C-Reactive Protein in Hematological Testing 4
...X/See™ is a 1-step, hand-held, point-of-care...rug metabolites in human urine. The TOX/See devic...d drugs in 3 to 8 minutes and requires only a few ...lly packaged to maximize convenience and ease of u...
...X/See™ is a 1-step, hand-held, point-of-care...rug metabolites in human urine. The TOX/See devic...d drugs in 3 to 8 minutes and requires only a few ...lly packaged to maximize convenience and ease of u...
...X/See™ is a 1-step, hand-held, point-of-care...rug metabolites in human urine. The TOX/See devic...d drugs in 3 to 8 minutes and requires only a few ...lly packaged to maximize convenience and ease of u...
...X/See™ is a 1-step, hand-held, point-of-care...rug metabolites in human urine. The TOX/See devic...d drugs in 3 to 8 minutes and requires only a few ...lly packaged to maximize convenience and ease of u...
Medicine Products: